EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Estimated cytomegalovirus seroprevalence in the general population of the United States and Canada

W Dana Flanders, Cathy Lally, Anne Dilley, John Diaz-Decaro

Journal of Medical Virology · 2024-03 · 96 (3)

DOI: 10.1002/jmv.29525 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 26.03.2024. Verfasst von W Dana Flanders und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Cytomegalovirus, Cytomegalovirus Infections. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moderna, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seroprevalence data for cytomegalovirus (CMV), a widespread virus causing lifelong infection, vary widely, and contemporary data from the United States (US) and Canada are limited. Utilizing a modeling approach based on a literature review (conducted August, 2022) of data published since 2005, we determine age‐, sex‐, and country‐specific CMV seroprevalence in the general US and Canadian populations. Sex‐specific data were extracted by age categories, and a random‐effects meta‐regression model was used to fit the reported data (incorporating splines for the US). Seven studies reported US CMV seroprevalence (both sexes, aged 1‒89 years); all used National Health and Nutrition Examination Survey data. Due to limited population‐based studies, Canadian estimates were modeled using other limited country data. In both countries, modeled seroprevalence estimates increased with age and were higher in females versus males (US: 49.0% vs . 41.6% at 18‒19 years; 61.5% vs . 50.0% at 38‒39 years; Canada: 23.7% vs . 13.7% at 18‒19 years; 32.6% vs . 22.6% at 38‒39 years). Notably, by young adulthood, one‐half of US and one‐quarter of Canadian females have acquired CMV. The observed differences in CMV seroprevalence in the US and Canada may partially reflect variations in general population characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusCytomegalovirus InfectionsMaleFemaleHumansUnited StatesYoung AdultAdultNutrition SurveysSeroepidemiologic StudiesAntibodies, ViralCanada

Stichwörter der Autor:innen

CMVcongenital cytomegaloviruscytomegalovirusepidemiologyseroprevalence

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Epidemiologic Research & Methods, LLC, Southport, NC, USA.
  • Epidemiology, Moderna, Inc., Cambridge, MA, USA.

Förderung

  • Moderna, Inc.

Zitieren

APA

Dana Flanders, W., Lally, C., Dilley, A., & Diaz-Decaro, J. (2024). Estimated cytomegalovirus seroprevalence in the general population of the United States and Canada. Journal of Medical Virology, 96(3). https://doi.org/10.1002/jmv.29525

Vancouver

Dana Flanders W, Lally C, Dilley A, Diaz-Decaro J. Estimated cytomegalovirus seroprevalence in the general population of the United States and Canada. Journal of Medical Virology. 2024;96(3). doi:10.1002/jmv.29525

BibTeX
@article{DanaFlanders2024,
  author = {Dana Flanders, W and Lally, Cathy and Dilley, Anne and Diaz-Decaro, John},
  title = {Estimated cytomegalovirus seroprevalence in the general population of the United States and Canada},
  journal = {Journal of Medical Virology},
  year = {2024},
  volume = {96},
  number = {3},
  doi = {10.1002/jmv.29525}
}
Kostenlos starten →